Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

08 Nov, EOD - Indian

SENSEX 79486.32 (-0.07)

Nifty 50 24148.2 (-0.21)

Nifty Bank 51561.2 (-0.68)

Nifty IT 42050.15 (0.71)

Nifty Midcap 100 56352 (-1.33)

Nifty Next 50 69774.2 (-1.23)

Nifty Pharma 22542.25 (0.07)

Nifty Smallcap 100 18445.6 (-1.70)

08 Nov, EOD - Global

NIKKEI 225 39500.37 (0.30)

HANG SENG 20728.19 (-1.07)

S&P 6005.47 (0.46)

LOGIN HERE

Cancel

LOGIN HERE

Cancel

BSE Code : 506820 | NSE Symbol : ASTRAZEN | ISIN : INE203A01020 | Industry : Pharmaceuticals |

Profit and Loss

Particulars (₹ Cr)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue From Operations	1,295.53	1,002.97	805.60	813.56	831.81
Sale of Products	1,205.64	941.75	761.42	776.79	801.26
Sale of Services	89.89	61.22	44.18	36.77	30.51
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	0.00	0.00	0.00	0.00	0.04
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	1,295.53	1,002.97	805.60	813.56	831.81
Other Income	34.80	26.10	14.76	12.84	12.99
Total Revenue	1,330.33	1,029.07	820.36	826.40	844.80
Changes in Inventories	-33.77	-48.86	14.47	2.95	-39.21
Cost of Material Consumed	129.02	84.38	89.61	97.26	70.21
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	499.31	324.46	207.88	194.74	274.23
Employee Benefits	241.45	259.10	230.21	219.54	216.70
Total Other Expenses	275.07	218.77	177.25	163.60	189.18
Manufacturing / Operating Expenses	19.25	19.33	16.15	16.48	16.76
Administrative and Selling Expenses	234.33	185.72	145.09	129.72	157.18
Other Expenses	21.49	13.72	16.01	17.40	15.24
Finance Costs	1.20	0.63	0.95	1.09	1.14
Depreciation and Amortization	14.94	16.26	16.95	20.13	18.58
Total Expenses	1,127.22	854.74	737.32	699.31	730.83
Profit Before Exceptional Items and Tax	203.11	174.33	83.04	127.09	113.97
Exceptional Items Before Tax	16.43	-40.23	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	219.54	134.10	83.04	127.09	113.97
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	219.54	134.10	83.04	127.09	113.97
Taxation	58.03	34.81	21.44	33.79	41.76
Current Tax	53.55	38.30	22.63	34.83	31.51
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.90	-3.49	-1.19	-1.04	10.25
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	5.38	0.00	0.00	0.00	0.00
Profit After Tax	161.51	99.29	61.60	93.30	72.21
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	161.51	99.29	61.60	93.30	72.21
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	161.51	99.29	61.60	93.30	72.21
Earning Per Share - Basic	64.60	39.70	24.60	37.30	28.90
Earning Per Share - Diluted	64.60	39.70	24.60	37.30	28.90

LOGIN HERE

LOGIN HERE

Astrazeneca Pharma India Ltd

Profit and Loss